This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Obesity Science & Innovation USA (OSI USA)
September 23-24, 2026
Hynes Convention CenterBoston, United States
Book Now
Menu
Book

Lloyd Tran
CEO at Biomed Industries
Speaker

Agenda Sessions

  • NA-931: A Quadruple Receptor Agonist for Weight Loss Therapy Without Muscle Loss

    , 14:10
    View Session

At this event

Prev
Next
Robrecht Thoonen
Senior Director External Innovation, Diabetes, Obesity & Cardiometabolic
Eli Lilly

See Lloyd at Obesity Science & Innovation USA (OSI USA)

Book Now